INS and metabolic dysfunction-associated steatotic liver disease: FFAs cause insulin resistance, increase glucose production, impair the ability of hepatocytes to degrade insulin, provoke hyperinsulinemia and consequently increase triglyceride synthesis, hepatic steatosis and non-alcoholic fatty liver disease (NAFLD)4.